CONMED CorporationWeak constant currency growth and flat projected sales limit competitive position
StockStory identified Jabil as a profitable stock with solid fundamentals to watch, while recommending investors avoid Rapid7 and CONMED. Jabil, with a $33.59 billion revenue base and a 34.7% return on capital, has seen earnings per share growth outpace revenue due to share buybacks. Rapid7 faces flat billings and declining operating margins as costs rise faster than revenue. CONMED struggles with weak constant currency growth and flat projected sales, limiting its competitive position against larger peers.
CONMED CorporationWeak constant currency growth and flat projected sales limit competitive position
Jabil Circuit IncSolid fundamentals, high return on capital, and EPS growth from buybacks make it a stock to watch
Rapid7 IncFlat billings and declining operating margins as costs rise faster than revenue